5
Clinical Trials associated with FB-3001A phase 1, open label study to evaluate MTD, safety, tolerability and pharmacokinetics of oral drug AB001 in patients with various types of metastatic cancer patients.
/ RecruitingNot Applicable A Prospective, open label, Case study to determine the safety and efficacy of AB001 with Standard of Care in patients with advanced metastatic cancer
A Phase 1, Placebo-controlled, Randomized, Parallel Group Study to Evaluate the Tolerability, Safety and Pharmacokinetics of a Topical Patch AB001 Following Single and Repeated Administration in Healthy Subjects
The study evaluates the safety, tolerability and pharmacokinetics of single and repeated doses of topical AB001 patch and the bioavailability relative to the oral capsule and topical positive comparative patch.
100 Clinical Results associated with FB-3001
100 Translational Medicine associated with FB-3001
100 Patents (Medical) associated with FB-3001
100 Deals associated with FB-3001